HIF1A-As2 guides its binding protein DHX9 to stimulate MYC signalling, whereas activated MYC, in turn, could transcriptionally activate HIF1A-As2 expression, suggesting HIF1A-As2 and MYC form a double-positive loop that may robustly alter downstream genes and tumor growth. The gene discussed is DHX9; the disease is neoplasm.